Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ferris

Showing results (661-670 of 818) with videos related to

Pageof 82
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|February 15, 2015
Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3Dmitri Madera, Lynn Vitale-Cross, Daniel Martin, et al.
JCO Precision Oncology|November 20, 2024
CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A ReviewKevin J Contrera, Matthew E Spector, Liron Pantanowitz, et al.
Cancers|June 10, 2022
A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid CancerJulie E Bauman, Zhengjia Chen, Chao Zhang, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Dose-ranging study of lutein supplementation in persons aged 60 years or olderJulie M Rosenthal, Jonghyeon Kim, Francisco de Monasterio, et al.
Translational Vision Science & Technology|April 26, 2019
A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons LearnedAnn-Margret Ervin, Rupert W Strauss, Mohamed I Ahmed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2025
Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II StudyShailender Bhatia, Suzanne L Topalian, William Sharfman, et al.
Ophthalmology|August 5, 2008
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edemaDavid J Browning, Adam R Glassman, Lloyd P Aiello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid TumorsBonnie S Glisson, Rom S Leidner, Robert L Ferris, et al.
Bone Marrow Transplantation|March 9, 2021
Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort studyAlexandra A Pietraszkiewicz, Debbie Payne, Maria Abraham, et al.
Frontiers in Pharmacology|July 5, 2017
Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer PatientsZaima Mazorra, Anabel Lavastida, Fernando Concha-Benavente, et al.
Pageof 82

Showing results (661-670 of 818) with videos related to

Sort By:
Pageof 82
Cancer Prevention Research (Philadelphia, Pa.)|February 15, 2015
Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3Dmitri Madera, Lynn Vitale-Cross, Daniel Martin, et al.
JCO Precision Oncology|November 20, 2024
CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A ReviewKevin J Contrera, Matthew E Spector, Liron Pantanowitz, et al.
Cancers|June 10, 2022
A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid CancerJulie E Bauman, Zhengjia Chen, Chao Zhang, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Dose-ranging study of lutein supplementation in persons aged 60 years or olderJulie M Rosenthal, Jonghyeon Kim, Francisco de Monasterio, et al.
Translational Vision Science & Technology|April 26, 2019
A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons LearnedAnn-Margret Ervin, Rupert W Strauss, Mohamed I Ahmed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2025
Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II StudyShailender Bhatia, Suzanne L Topalian, William Sharfman, et al.
Ophthalmology|August 5, 2008
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edemaDavid J Browning, Adam R Glassman, Lloyd P Aiello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid TumorsBonnie S Glisson, Rom S Leidner, Robert L Ferris, et al.
Bone Marrow Transplantation|March 9, 2021
Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort studyAlexandra A Pietraszkiewicz, Debbie Payne, Maria Abraham, et al.
Frontiers in Pharmacology|July 5, 2017
Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer PatientsZaima Mazorra, Anabel Lavastida, Fernando Concha-Benavente, et al.
Pageof 82